FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

871699001: Pemigatinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3973903014 Pemigatinib en Synonym Active Entire term case insensitive SNOMED CT core module
3973904015 Pemigatinib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pemigatinib Is a Heterocyclic compound true Inferred relationship Existential restriction modifier
Pemigatinib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Pemigatinib Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Pemigatinib Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Pemigatinib Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Pemigatinib Inferred relationship Existential restriction modifier 1
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pemigatinib Inferred relationship Existential restriction modifier 1
Product containing precisely pemigatinib 9 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Pemigatinib Inferred relationship Existential restriction modifier 1
Product containing precisely pemigatinib 9 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pemigatinib Inferred relationship Existential restriction modifier 1
Product containing precisely pemigatinib 13.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Pemigatinib Inferred relationship Existential restriction modifier 1
Product containing precisely pemigatinib 13.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pemigatinib Inferred relationship Existential restriction modifier 1
Product containing only pemigatinib in oral dose form (medicinal product form) Has active ingredient True Pemigatinib Inferred relationship Existential restriction modifier 1
Product containing pemigatinib in oral dose form (medicinal product form) Has active ingredient True Pemigatinib Inferred relationship Existential restriction modifier 1
Pemigatinib Has active ingredient True Pemigatinib Inferred relationship Existential restriction modifier 1
Product containing pemigatinib (medicinal product) Has active ingredient True Pemigatinib Inferred relationship Existential restriction modifier 1
Pemigatinib 4.5mg tablets 14 tablet Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemigatinib 9mg tablets 14 tablet Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemazyre 9mg tablets (Incyte Biosciences UK Ltd) Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemigatinib 9mg tablets Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemigatinib 4.5mg tablets Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemigatinib 13.5mg tablets Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemazyre 4.5mg tablets (Incyte Biosciences UK Ltd) 14 tablet Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemigatinib 13.5mg tablets 14 tablet Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemazyre 4.5mg tablets (Incyte Biosciences UK Ltd) Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemazyre 9mg tablets (Incyte Biosciences UK Ltd) 14 tablet Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemazyre 13.5mg tablets (Incyte Biosciences UK Ltd) Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier
Pemazyre 13.5mg tablets (Incyte Biosciences UK Ltd) 14 tablet Has specific active ingredient True Pemigatinib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start